#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital leptin deficiency Hypophosphatasia Pyruvate dehydrogenase complex deficiency Acquired C1 inhibitor deficiency Propionic acidaemia Paget's disease of the vulva Adenocarcinoma pancreas Malignant glioma Idiopathic pulmonary fibrosis Pleural mesothelioma Nodal marginal zone B-cell lymphoma Fontan procedure Arterial disorder Neurodevelopmental disorder Frontotemporal dementia More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Treatment Turner’s syndrome – Life with Disease Ewing’s sarcoma – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Rosai-Dorfman syndrome – Basic Information Haemophilia A without inhibitors – Basic Information Osteosarcoma – Basic Information Mantle cell lymphoma stage III – Treatment Leiomyosarcoma – Basic Information Leiomyosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mepacrine Pentoxifylline AMODIAQUINE Romidepsin Opium, Standardized Powdered Ibrutinib Cholesterol Anastrozole Sabatolimab Fluconazole Resiniferatoxin Insulin Human (Rdna) Vafidemstat Clomipramine Hydrochloride Thiamine Nitrate Vudalimab Bleomycin 177Lu-Rhpsma-10.1 Nesolicaftor Gadoquatrane More therapies…

    Learn about Your Condition

    Food allergy Hysterectomy Cardiac amyloidosis Mantle cell lymphoma Endometrial adenocarcinoma Arterial stiffness Chordoma Polycythaemia vera Cancer pain Hypochromic anaemia Anaplastic thyroid cancer Glomerulonephritis chronic Critical illness Cartilage injury Hypertriglyceridaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic scleroderma

  • Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • CC-97540
    • Fludarabine Phosphate
    • Nintedanib
    Belgium France Germany Italy Spain

  • Lebrikizumab in Adults with Moderate to Severe Localized Scleroderma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Lebrikizumab
    Germany

  • Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    France

  • A study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic scleroderma
    Germany Spain

  • Comparing Dapagliflozin and Tocilizumab for Treating Patients with Systemic Sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Dapagliflozin
    • Sodium Chloride
    • Tocilizumab
    Poland

  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Systemic scleroderma
    • Systemic lupus erythematosus
    Investigated Drugs:
    • TETANUS TOXOID
    The Netherlands
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!